Annovis Bio, Inc. (ANVS) NYSE
1.85
+0.03(+1.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 71.11M |
| Enterprise Value | 51.58M |
| P/E Ratio | -1.25 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 16.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -2.52 |
| Return On Equity | -3.18 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -29.7M |
| Net Income | -28.85M |
| Diluted EPS | -1.4 |
Balance Sheet
| Total Cash | 14.22M |
| Total Cash/Share | 0.51 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.27 |
| Book Value Per Share | 0.11 |
Price History
| 52-Week Change | -30.49 |
| 52-Week High | 5.5 |
| 52-Week Low | 1.54 |
| Moving Average 50 Days | 2.06 |
| Moving Average 200 Days | 2.61 |
Statistics
| Average Volume | 1.02M |
| Shares Outstanding | 19.67M |
| % Held by Institutions | 19.03 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
